As results season winds down, Dan Jones and team discuss a property group’s results, alternative ways to find bargain stocks and Novo Nordisk vs Eli Lilly ...

More than a million Britons are now injecting themselves weekly with drugs-bought online or through private clinics-lured by ...

The injection was initially licensed to treat type 2 diabetes, but is now also prescribed to help with weight loss ...

By Brooke Hudspeth, Pharm.D. University of Kentucky You’ve likely heard about glucagon-like peptide-1 agonists – usually ...

Eli Lilly is to raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170pc to be in line with other European markets, it has said, as the pharma industry responds ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...

Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.

A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...

Medicare enrollees who buy the optional Part D drug benefit may see price hikes of up to $50 a month when they shop for next ...

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

Current weight-loss and diabetes medications, such as GLP-1 drugs, often fail to deliver lasting results and are plagued by ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...